Hydroxyapatite/polylactide biphasic combination scaffold loaded with dexamethasone for bone regeneration. 2011

Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
Department of Oral and Maxillofacial Surgery, School of Dentistry, Chosun University, Gwangju, Republic of Korea.

This study presents a novel design of a ceramic/polymer biphasic combination scaffold that mimics natural bone structures and is used as a bone graft substitute. To mimic the natural bone structures, the outside cortical-like shells were composed of porous hydroxyapatite (HA) with a hollow interior using a polymeric template-coating technique; the inner trabecular-like core consisted of porous poly(D,L-lactic acid) (PLA) that was loaded with dexamethasone (DEX) and was directly produced using a particle leaching/gas forming technique to create the inner diameter of the HA scaffold. It was observed that the HA and PLA parts of the fabricated HA/PLA biphasic scaffold contained open and interconnected pore structures, and the boundary between both parts was tightly connected without any gaps. It was found that the structure of the combination scaffold was analogous to that of natural bone based on micro-computed tomography analysis. Additionally, the dense, uniform apatite layer was formed on the surface of the HA/PLA biphasic scaffold through a biomimetic process, and DEX was successfully released from the PLA of the biphasic scaffold over a 1-month period. This release caused human embryonic palatal mesenchyme cells to proliferate, differentiate, produce ECM, and form tissue in vitro. Therefore, it was concluded that this functionally graded scaffold is similar to natural bone and represents a potential bone-substitute material.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D011091 Polyesters Polymers of organic acids and alcohols, with ester linkages--usually polyethylene terephthalate; can be cured into hard plastic, films or tapes, or fibers which can be woven into fabrics, meshes or velours. Polyester
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001861 Bone Regeneration Renewal or repair of lost bone tissue. It excludes BONY CALLUS formed after BONE FRACTURES but not yet replaced by hard bone. Osteoconduction,Bone Regenerations,Regeneration, Bone,Regenerations, Bone
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
October 2010, Journal of biomedical materials research. Part B, Applied biomaterials,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2014, Molecular biology reports,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2022, American journal of translational research,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2018, International journal of nanomedicine,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
February 2021, Carbohydrate polymers,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2023, International journal of nanomedicine,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2022, Materials science & engineering. C, Materials for biological applications,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2020, In vivo (Athens, Greece),
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
January 2022, Tissue engineering. Part A,
Jun-Sik Son, and Su-Gwan Kim, and Ji-Su Oh, and Mark Appleford, and Sunho Oh, and Joo L Ong, and Kyu-Bok Lee
May 2017, Journal of biomedical materials research. Part B, Applied biomaterials,
Copied contents to your clipboard!